Suzuki H, Kinlough-Rathbone R L, Packham M A, Tanoue K, Yamazaki H, Mustard J F
Department of Pathology, McMaster University, Hamilton, Ontario, Canada.
Blood. 1988 May;71(5):1310-20.
Because thrombin aggregates afibrinogenemic platelets and platelets from patients with the gray platelet syndrome and because antibodies to fibrinogen inhibit thrombin-induced aggregation only at low concentrations of thrombin, the role of fibrinogen in the formation of thrombin-induced aggregates was investigated further with human platelets washed and resuspended in Tyrode-albumin solution containing apyrase, either with or without added Ca2+ (2 mmol/L). Samples for immunocytochemical assessment of fibrinogen distribution were taken at several times (up to five minutes) after aggregation induced by 0.5 U/mL of thrombin. Glutaraldehyde-fixed samples were embedded in Lowicryl K4M, sectioned, incubated with goat antihuman fibrinogen, washed, reacted with gold-labeled antigoat IgG, and prepared for electron microscopy. By 10 seconds, small aggregates formed, and granules were centralized; alpha granules were heavily labeled with immunogold, but the platelet surface was not. As large aggregates formed, granule swelling or fusion occurred, and in some areas granule material seemed to be in contact with the exterior. In these experiments with no added fibrinogen, there were some clusters of gold particles on the platelet surfaces remote from sites of granule discharge, but there were large areas where platelets were in close contact with little or no fibrinogen detectable between them. No fibrin was visible up to five minutes after the addition of thrombin, which indicated that fibrinogen from the granules does not readily become available for fibrin formation in the ambient fluid. Similar results were obtained in media with and without added Ca2+. Thus at least some aggregation in response to thrombin can occur without the participation of released fibrinogen, and much of the granule fibrinogen appears to remain localized at sites where granules fuse with the plasma membrane or the open canalicular system. Incubation of unstirred samples with thrombin for ten minutes resulted in the formation of small aggregates, extensive gold label in regions connected to the exterior of the platelets, but very little gold labeling of the platelet membrane and no visible fibrin formation. When the platelets were aggregated in the presence of external fibrinogen, the morphological changes within the platelets were the same, but fibrinogen rapidly became associated with the entire platelet surface, and visible fibrin formed within 30 seconds in the medium containing 2 mmol/L Ca2+.(ABSTRACT TRUNCATED AT 400 WORDS)
由于凝血酶可使无纤维蛋白原血症患者的血小板以及灰色血小板综合征患者的血小板聚集,且纤维蛋白原抗体仅在低浓度凝血酶时抑制凝血酶诱导的聚集,因此,使用洗涤后重悬于含抑肽酶的泰罗德白蛋白溶液中的人血小板,在添加或不添加Ca2+(2 mmol/L)的情况下,进一步研究纤维蛋白原在凝血酶诱导聚集体形成中的作用。在0.5 U/mL凝血酶诱导聚集后的几个时间点(最长5分钟)采集样本,用于纤维蛋白原分布的免疫细胞化学评估。戊二醛固定的样本包埋在Lowicryl K4M中,切片,与山羊抗人纤维蛋白原孵育,洗涤,与金标记的抗山羊IgG反应,然后制备用于电子显微镜观察。到10秒时,形成小聚集体,颗粒集中;α颗粒被免疫金大量标记,但血小板表面未被标记。随着大聚集体的形成,颗粒肿胀或融合,在某些区域颗粒物质似乎与外部接触。在这些未添加纤维蛋白原的实验中,远离颗粒释放部位的血小板表面有一些金颗粒簇,但在很大区域内血小板紧密接触,其间几乎检测不到或没有纤维蛋白原。添加凝血酶后5分钟内未见纤维蛋白,这表明颗粒中的纤维蛋白原不易在周围液体中用于纤维蛋白形成。在添加和不添加Ca2+的培养基中均获得了类似结果。因此,至少部分对凝血酶的聚集可在无释放的纤维蛋白原参与的情况下发生,且许多颗粒纤维蛋白原似乎仍定位在颗粒与质膜或开放小管系统融合的部位。将未搅拌的样本与凝血酶孵育10分钟导致形成小聚集体,在与血小板外部相连的区域有广泛的金标记,但血小板膜的金标记很少,且未见可见的纤维蛋白形成。当血小板在外部纤维蛋白原存在下聚集时,血小板内的形态变化相同,但纤维蛋白原迅速与整个血小板表面结合,并且在含2 mmol/L Ca2+的培养基中30秒内形成可见的纤维蛋白。(摘要截于400字)